← All trials
NCT06360250
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 10, 2024
- Primary completion
- Oct 30, 2024
- Completion date
- Oct 30, 2024
- First posted
- Apr 11, 2024
- Last posted
- Apr 11, 2024
- Enrollment
- 190
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Changchun BCHT Biotechnology Co.Lead sponsor
- Anning City First People's HospitalCollaborator
- Yunnan University of Traditional Chinese MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.